COVID-19: Drugs in Development


The COVID-19 outbreak, which started in December 2019 in Wuhan City, China, was declared a "Public Health Emergency of International Concern" by the WHO on January 30, 2020. The outbreak was characterized as a pandemic on March 11, 2020.

Currently, there are no drugs to treat COVID-19, caused by the novel coronavirus SARS-CoV-2.

Listed below are companies that are in the race to find a treatment or vaccine for the novel coronavirus.

Subscribe to RTT Intelligent Investor for FREE 7-Day Trial with complete access to COVID-19 Drugs in Development Calendar.

Company Name
Current Stage
Next Milestone
Last Updated
Incyte Corporation
Phase 3 trial of Olumiant in hospitalized participants with COVID-19, dubbed COV-BARRIER
Results expected in December 2020
Incyte Corporation
Phase 3 trial of Jakafi in patients with COVID-19-associated Acute Respiratory Distress Syndrome who require mechanical ventilation (RUXCOVID-DEVENT)
Relief Therapeutics Holding AG
US Phase 2b/3 clinical trials of RLF-100 in respiratory deficiency due to COVID-19
Topline data expected in Q4, 2020
Altimmune Inc.
AdCOVID Intranasal Covid-19 vaccine
Positive results from the preclinical studies of AdCOVID announced on Jul.13
Phase 1 clinical trial of AdCOVID in Q4 2020
Vigene Biosciences, DynPort Vaccine Co.
Phase III trial of Lenzilumab in severe and critical COVID-19 patients
Topline data expected in Q4, 2020
Hepion Pharmaceuticals, Inc.
Preclinical stage
National Institute of Allergy and Infectious Diseases
Immunic, Inc
IMU-838 for COVID-19.
Phase 2b study in combination with Tamiflu in adult patients with moderate-to-severe COVID-19 (IONIC)
Top-line data expected later in 2020
University Hospitals Coventry and Warwickshire NHS Trust
Atreca Inc.
Antibody Treatment for COVID-19
Begin clinical testing in the first half of 2021
BeiGene Ltd. (BGNE) and IGM Biosciences Inc. (IGMS)

Get Full Access to latest records of COVID-19 Drugs in Development Calendar by subscribing to RTT Intelligent Investor with FREE 7-Day Trial. (No Credit Card Required)

Editors Pick
NASA's Osiris-Rex robotic spacecraft briefly touched down on near-Earth asteroid Bennu's surface on Tuesday to collect rock and dust samples that will be brought back to Earth in 2023. Bennu is currently more than 200 million miles, or 321 million kilometres, from Earth. Osiris-Rex launched from Cape Canaveral Air Force Station in Florida in September 2016. Amazon said Wednesday that free one-hour grocery pickup is now available to prime members at all U.S. Whole Foods Market locations. Previously, the prime members could pick up Whole Foods orders only at select stores. J.C. Penney said it is near to exiting Chapter 11 ahead of the busy December 2020 holiday season. The beleaguered retailer filed a draft asset purchase agreement towards finalization of the acquisition by Brookfield Asset Management, Inc. and Simon Property Group, Inc. They are expected to buy substantially all of J.C. Penney's retail and operating assets in a combination of cash and debt.